Invictus MD Strategies EV/EBIT
Was ist das EV/EBIT von Invictus MD Strategies?
EV/EBIT von Invictus MD Strategies Corp. ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Invictus MD Strategies
Was macht Invictus MD Strategies?
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.
Unternehmen mit ev/ebit ähnlich Invictus MD Strategies
- Gritstone Bio Inc hat EV/EBIT von N/A
- Barnwell Industries hat EV/EBIT von N/A
- Sweet Earth hat EV/EBIT von N/A
- Qutoutiao Inc hat EV/EBIT von N/A
- ManifestSeven hat EV/EBIT von N/A
- Avidian Gold hat EV/EBIT von N/A
- Invictus MD Strategies hat EV/EBIT von N/A
- ObsEva SA hat EV/EBIT von N/A
- Pharnext SA hat EV/EBIT von N/A
- TransAtlantic Petroleum Ltd hat EV/EBIT von N/A
- Q-Gold Resources hat EV/EBIT von N/A
- Marinus Pharmaceuticals Inc hat EV/EBIT von N/A
- Jaguar Health Inc hat EV/EBIT von N/A